New Zealand shares rose led by A2 Milk amid optimism it will stand to benefit from Chinese efforts to reduce the number of infant formula brands available in its market, while Xero reached a three-year high as investors were drawn back to its growth story.
The S&P/NZX 50 Index rose 54.48 points, or 0.7 per cent, to 7,693.99. Within the index, 34 stocks rose, nine fell and seven were unchanged. Turnover was $164 million.
A2 rose 3 per cent to $4.41, coming within 11 cents of the record reached last week. In May, the company lifted annual sales guidance for the second time in as many months to reflect Chinese demand. Xero, the cloud-based accounting services company, rose 1.1 per cent to $26.38, having reached as high as $26.45 in intraday trading.
"These are examples of where investors have fallen back in love with a couple of the favoured growth stocks," said Greg Smith, head of research at Fat Prophets in Auckland. "With the Chinese trying to reduce the number of brands available to maintain an emphasis on quality, if A2 is one of the brands left standing then that's great for them," he said.
With Xero, "you wouldn't say it was cheap but that's probably never been the case and the market is happy to back a growth story," he said. "It is not without peril in terms of competition in the US but the market continues to be prepared to give them the benefit of the doubt." The stock was at a key area of resistance given it hasn't been higher since 2014 but "if it sails through $26.50, technically we're going back into the $30s."
